2012
Safety of bevacizumab in metastatic breast cancer patients undergoing surgery Cortés J, Caralt M, Delaloge S, et al (Vall d'Hebron Univ Hosp, Barcelona, Spain; Institut Gustave Roussy, Villejuif Cedex, France; et al) Eur J Cancer 48:475-481, 2012§
Dominici L, Golshan M. Safety of bevacizumab in metastatic breast cancer patients undergoing surgery Cortés J, Caralt M, Delaloge S, et al (Vall d'Hebron Univ Hosp, Barcelona, Spain; Institut Gustave Roussy, Villejuif Cedex, France; et al) Eur J Cancer 48:475-481, 2012§. Breast Diseases A Year Book Quarterly 2012, 23: 351-352. DOI: 10.1016/j.breastdis.2012.09.015.Peer-Reviewed Original ResearchMetastatic breast cancer patientsSafety of bevacizumabBreast cancer patientsCancer patientsBevacizumab
2009
Surgical Complications and the Use of Neoadjuvant Bevacizumab.
Golshan M, Garber J, Gelman R, Tung N, Smith B, Troyan S, Greenberg C, Winer E, Ryan P. Surgical Complications and the Use of Neoadjuvant Bevacizumab. Cancer Research 2009, 69: 43-43. DOI: 10.1158/0008-5472.sabcs-09-43.Peer-Reviewed Original ResearchTriple-negative breast cancerDefinitive local therapyPhase II trialPostoperative complicationsNeoadjuvant cisplatinDefinitive surgeryII trialWound breakdownLocal therapyMedian ageBreast cancerSingle-arm phase II trialArm phase II trialTwo-sided Fisher's exact testClinical stage IIDose-dense ACSafety of bevacizumabOperable breast cancerBreast cancer surgerySingle-arm trialNegative breast cancerFisher's exact testCycles cisplatinNeoadjuvant bevacizumabNeoadjuvant setting